Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | EVP, Marketing & Sales | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 25,703 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Tax withholding · Disposed 487 · Balance 25,703 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2022 Filed May 17, 2022 11:32 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 2,868 | $56.78 | $162,845.04 |
DisclosureSEC source: 0001104659-22-061697 · tm2215773-1_4seq1.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,304 Read SEC document |
| May 04, 2022 Filed May 6, 2022 18:53 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 482 | $55.34 | $26,673.88 |
DisclosureSEC source: 0001104659-22-056936 · tm2214787-2_4seq1.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,172 Read SEC document |
| May 03, 2022 Filed May 5, 2022 19:56 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 462 | $54.44 | $25,151.28 |
DisclosureSEC source: 0001104659-22-056429 · tm2214663-2_4seq1.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,654 Read SEC document |
| May 02, 2022 Filed May 4, 2022 19:18 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 8,525 | $0.00 Strike: $54.47 | $0.00 |
DisclosureSEC source: 0001104659-22-055767 · tm2214507d2_4seq1.xml · derivative · entry 2 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,525 Underlying: Common Stock · 8,525 shares Expires 2032-05-02 F2 · derivative.exercise_date: The Options vest in three installments of 2,841 shares on May 2, 2023 and 2,842 shares each on May 2, 2024 and 2025. Read SEC document |
| May 02, 2022 Filed May 4, 2022 19:18 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055767 · tm2214507d2_4seq1.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,116 F1 · shares: The Restricted Stock vests in three equal installments each of 1,020 shares on May 2, 2023, 2024 and 2025. Read SEC document |
| May 04, 2021 Filed May 7, 2021 01:00 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 472 | $44.32 | $20,919.04 |
DisclosureSEC source: 0001104659-21-062637 · tm2115512-3_4seq1.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,056 Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:28 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 10,965 | $0.00 Strike: $44.33 | $0.00 |
DisclosureSEC source: 0001104659-21-061752 · tm2115301-5_4seq1.xml · derivative · entry 2 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,965 Underlying: Common Stock · 10,965 shares Expires 2031-05-03 F2 · derivative.exercise_date: The options vest in three equal installments each of 3,655 shares on May 3, 2022, 2023 and 2024. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:28 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-061752 · tm2115301-5_4seq1.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,528 F1 · shares: The restricted stock units vest in three installments of 1,190 shares on May 3, 2022 and 1,191 shares each on May 3, 2023 and 2024. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:37 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 11,549 | $0.00 Strike: $39.98 | $0.00 |
DisclosureSEC source: 0001104659-20-057481 · tm2018844d3_4.xml · derivative · entry 2 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,549 Underlying: Common Stock · 11,549 shares Expires 2030-05-04 F2 · derivative.exercise_date: The option vests in three installments as follows: 3,850 shares each on May 4, 2021 and 2022 and 3,849 shares on May 4, 2023. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:37 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 3,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-057481 · tm2018844d3_4.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,956 F1 · shares: The restricted stock units vest in three equal installments of 1,223 shares each on May 4, 2021, 2022 and 2023. Read SEC document |
| May 13, 2019 Filed May 16, 2019 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 21,194 | $0.00 Strike: $30.19 | $0.00 |
DisclosureSEC source: 0001144204-19-026828 · tv521809_form4.xml · derivative · entry 2 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,194 Underlying: Common Stock · 21,194 shares Expires 2029-05-13 F2 · derivative.exercise_date: The option vests and becomes exercisable on the third anniversary of the grant date. Read SEC document |
| May 13, 2019 Filed May 16, 2019 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-026828 · tv521809_form4.xml · nonDerivative · entry 1 Mekhail Adel · CIK 0001776953 · EVP, Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,287 F1 · shares: The restricted stock units vest and convert to shares of common stock on the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.